chr12-40340400-G-A

Variant summary

Our verdict is Uncertain significance. The variant received 4 ACMG points: 9P and 5B. PP3PP5_Very_StrongBP4BS2

The NM_198578.4(LRRK2):​c.6055G>A​(p.Gly2019Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000411 in 1,613,804 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic,risk factor (★★).

Frequency

Genomes: 𝑓 0.00036 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00042 ( 1 hom. )

Consequence

LRRK2
NM_198578.4 missense

Scores

14
3
1

Clinical Significance

Pathogenic/Likely pathogenic; risk factor criteria provided, multiple submitters, no conflicts P:28O:2

Conservation

PhyloP100: 9.66

Publications

3213 publications found
Variant links:
Genes affected
LRRK2 (HGNC:18618): (leucine rich repeat kinase 2) This gene is a member of the leucine-rich repeat kinase family and encodes a protein with an ankryin repeat region, a leucine-rich repeat (LRR) domain, a kinase domain, a DFG-like motif, a RAS domain, a GTPase domain, a MLK-like domain, and a WD40 domain. The protein is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Mutations in this gene have been associated with Parkinson disease-8. [provided by RefSeq, Jul 2008]
LRRK2 Gene-Disease associations (from GenCC):
  • autosomal dominant Parkinson disease 8
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Genomics England PanelApp
  • Parkinson disease
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • hereditary late onset Parkinson disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 4 ACMG points.

PP3
Multiple lines of computational evidence support a deleterious effect 12: AlphaMissense, BayesDel_addAF, BayesDel_noAF, Cadd, Eigen, M_CAP, MutationAssessor, phyloP100way_vertebrate, PrimateAI, PROVEAN, REVEL, REVEL [when max_spliceai, FATHMM_MKL, MetaRNN, MutationTaster was below the threshold]
PP5
Variant 12-40340400-G-A is Pathogenic according to our data. Variant chr12-40340400-G-A is described in ClinVar as Pathogenic/Likely_pathogenic|risk_factor. ClinVar VariationId is 1940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP4
Computational evidence support a benign effect (MetaRNN=0.15880463). . Strength limited to SUPPORTING due to the PP5.
BS2
High AC in GnomAd4 at 55 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_198578.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LRRK2
NM_198578.4
MANE Select
c.6055G>Ap.Gly2019Ser
missense
Exon 41 of 51NP_940980.4

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LRRK2
ENST00000298910.12
TSL:1 MANE Select
c.6055G>Ap.Gly2019Ser
missense
Exon 41 of 51ENSP00000298910.7
LRRK2
ENST00000430804.5
TSL:1
n.*2728G>A
non_coding_transcript_exon
Exon 20 of 30ENSP00000410821.1
LRRK2
ENST00000430804.5
TSL:1
n.*2728G>A
3_prime_UTR
Exon 20 of 30ENSP00000410821.1

Frequencies

GnomAD3 genomes
AF:
0.000362
AC:
55
AN:
152064
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000725
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000852
Gnomad ASJ
AF:
0.00547
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000943
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000235
Gnomad OTH
AF:
0.000957
GnomAD2 exomes
AF:
0.000526
AC:
132
AN:
251154
AF XY:
0.000553
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.000260
Gnomad ASJ exome
AF:
0.00854
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000256
Gnomad OTH exome
AF:
0.000978
GnomAD4 exome
AF:
0.000417
AC:
609
AN:
1461622
Hom.:
1
Cov.:
31
AF XY:
0.000413
AC XY:
300
AN XY:
727112
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33452
American (AMR)
AF:
0.000403
AC:
18
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.00785
AC:
205
AN:
26126
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39694
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86256
European-Finnish (FIN)
AF:
0.0000187
AC:
1
AN:
53416
Middle Eastern (MID)
AF:
0.00173
AC:
10
AN:
5766
European-Non Finnish (NFE)
AF:
0.000274
AC:
305
AN:
1111818
Other (OTH)
AF:
0.00111
AC:
67
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
35
69
104
138
173
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000361
AC:
55
AN:
152182
Hom.:
0
Cov.:
33
AF XY:
0.000336
AC XY:
25
AN XY:
74402
show subpopulations
African (AFR)
AF:
0.0000723
AC:
3
AN:
41504
American (AMR)
AF:
0.000851
AC:
13
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.00547
AC:
19
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4808
European-Finnish (FIN)
AF:
0.0000943
AC:
1
AN:
10608
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000235
AC:
16
AN:
68008
Other (OTH)
AF:
0.000947
AC:
2
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
4
8
13
17
21
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000650
Hom.:
2
Bravo
AF:
0.000586
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000581
AC:
5
ExAC
AF:
0.000387
AC:
47
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.000382
EpiControl
AF:
0.000356

ClinVar

ClinVar submissions as Germline
Significance:Pathogenic/Likely pathogenic; risk factor
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
17
-
-
Autosomal dominant Parkinson disease 8 (18)
7
-
-
not provided (7)
1
-
-
Inborn genetic diseases (1)
1
-
-
LRRK2-related disorder (1)
1
-
-
Parkinson disease (1)
1
-
-
Parkinson disease, late-onset (1)
-
-
-
Young-onset Parkinson disease (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.94
BayesDel_addAF
Pathogenic
0.35
D
BayesDel_noAF
Pathogenic
0.57
CADD
Pathogenic
31
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.47
T
Eigen
Pathogenic
1.1
Eigen_PC
Pathogenic
1.0
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.96
D
M_CAP
Pathogenic
0.74
D
MetaRNN
Benign
0.16
T
MetaSVM
Pathogenic
1.0
D
MutationAssessor
Pathogenic
3.2
M
PhyloP100
9.7
PrimateAI
Pathogenic
0.90
D
PROVEAN
Pathogenic
-5.1
D
REVEL
Pathogenic
0.97
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.96
MVP
0.98
MPC
1.8
ClinPred
0.18
T
GERP RS
5.7
Varity_R
0.88
gMVP
0.92
Mutation Taster
=35/65
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34637584; hg19: chr12-40734202; COSMIC: COSV54172342; API